Agilon Health, Inc.
AGLNYSEHealthcare● Active
$99.19
+$2.34(+2.42%)
Market Cap$1.7B
P/E Ratio—
52W High$101.7603
52W Low$7.48
Agilon Health, Inc. (AGL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AGL · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $5.93B | $6.06B | $4.32B | $2.39B | $1.52B |
| Cost of Revenue | $6.12B | $6.06B | $4.25B | $2.28B | $1.46B |
| Gross Profit | ($0.19B) | $0.00B | $0.07B | $0.11B | $0.07B |
| Gross Margin %(computed) | -3.18% | 0.08% | 1.61% | 4.66% | 4.32% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.24B | $0.27B | $0.29B | $0.21B | $0.43B |
| Total Operating Expenses | $0.23B | $0.30B | $0.30B | $0.22B | $0.44B |
| Operating Income | ($0.42B) | ($0.29B) | ($0.23B) | ($0.11B) | ($0.37B) |
| Operating Margin %(computed) | -7.10% | -4.82% | -5.38% | -4.41% | -24.47% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.01B |
| Income Before Tax | ($0.40B) | ($0.25B) | ($0.19B) | ($0.09B) | ($0.38B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.41B) | ($0.26B) | ($0.26B) | ($0.11B) | ($0.41B) |
| Net Margin %(computed) | -6.83% | -4.29% | -6.08% | -4.46% | -26.72% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-24.50 | $-15.75 | $-16.00 | $-6.50 | $-27.25 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.01B |
| EBITDA | ($0.37B) | ($0.22B) | ($0.17B) | ($0.07B) | ($0.36B) |
| EBITDA Margin %(computed) | -6.22% | -3.60% | -3.88% | -3.03% | -23.80% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Agilon Health, Inc. data
About Agilon Health, Inc. (AGL) Income Statement
Agilon Health, Inc. (AGL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AGL reported revenue of $5.93B, gross profit of ($0.19B) (gross margin -3.18%), and net income of ($0.41B) — a net profit margin of -6.83%.
Frequently asked questions
AGL · 4 questionsAgilon Health, Inc. (AGL) reported revenue of $5.93B for 2025, down 2.1% year-over-year.
AGL revenueAGL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08